The Ultrasound Guided Pericapsular Nerve Group and Anterior Quadratus Lumborum Blocks in Hip Repl… (NCT06679764) | Clinical Trial Compass
CompletedPhase 4
The Ultrasound Guided Pericapsular Nerve Group and Anterior Quadratus Lumborum Blocks in Hip Replacement Surgeries
Egypt93 participantsStarted 2022-05-01
Plain-language summary
The investigators hypothesis that PENG block will produce effective opioid sparing analgesia with enhanced motor recovery more than AQLB in elderly patients undergoing total hip replacement surgeries
Who can participate
Age range65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Both genders
* Type of surgery; unilateral elective total hip replacement.
* Physical status ASA I- III
* Age ≥ 65 Years.
* Body mass index (BMI): \> 20 kg/m2 and \< 35 kg/m2.
* Traumatic fracture hip through anterolateral approach.
Exclusion Criteria:
* Patient refusal.
* Patients with known sensitivity or contraindication to drugs used in the study (local anesthetics \& opioids).
* History of psychological disorders and/or chronic pain.
* Pre- existing peripheral neuropathies
* Coagulopathy.
* Infection of the skin at the site of needle puncture area.
* Active cardiac condition (unstable coronary syndromes, significant arrhythmias, severe valvular disease).
* Acute respiratory disease (active chest infection, respiratory failure).
* Advanced liver disease (increased liver enzymes \>3 folds) or severe kidney disease (creatinine \>2).
* long operative time more than 3 hours.